{"ticker": {"uuid": "0bc627d9-8ec9-4db4-95f0-b4722598e807", "symbol": "U2TH34", "name": "United Therapeutics Corporation", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "United Therapeutics director Jan Malcolm sells $178,941 in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPeDVKWGdMVFVJT1FSRWhfaHNJWTB0S2xVb0o5SnYtRzZqdk9fQWlfWTdNQ3VUdGlZUUwyUEJ0ZkZzUmhYRFZ2N3pQT2pDbDZFZXdncFByMEo4UEItR0prWFk2Z2NRdEJEUG1KVW1faTVjc200cnpTOGpWSE1fX2hVRkZHU3JxbktwOVQwMUYyQ1FYMk1hTFVHRmtuQ0QzS3JMQndSTVlmay1hLVNUdm1tOWhiV1IwT3dpZHVuWERtVGs?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-10T20:44:02+00:00", "published_display": "10 Jul 2026 20:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Corp (UTHR) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 88/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNM0FTSkpGUHg3LVNHY0RXeTllTEVCeEc2RFRvaDZ3aVN0b2hnS3cwRGJKOFlLMmw4RFFsNnpOSVJHY2k4RmZYUnE3bWhoTU1BX2w1LURlTS13S1N5VUgxZTFmZC1FTzBmQVZmTFZ6TkFxbnFpdEx1cnh6NFFETGNQaFJwUWVFQjRLVWo4M3QzSDFjakNfek9ZR0wzdVZnWEs1bmxrb0VJdWNwMW9QYTVPNU1pcERXWnlnYXA3Z3NsVlpUekhaME9pQ1B0dThIZjlkMFE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-07T22:33:28+00:00", "published_display": "07 Jul 2026 22:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics CEO Rothblatt sells $5.2m in company stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPVXVQVkxPSHZrVThFMGxBYTd6dEpCdEFhUm9YNUpuRi1va1JLckVFcXg0dTRFcmVPUHJEM3NONFZ1bXlSVzZTMmttclFObGFscEtBcnBmNzYwUVJCdlhOcUdDb2FEb3dtbFM2VF9GT0xfNFZOMkdpNkN3X3l5QmE5NElaN0YwT3c0enREa1lpNDVqNU1Ia2xSbnV4OUYzaS0zX0lkNEVKdDlkSWZjN2lIWmFUb1dPSjJMVWNXQ1ZwVmRQbkNVT05QZnlJZ3NKUQ?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-07T18:54:01+00:00", "published_display": "07 Jul 2026 18:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Earnings Preview: Tyvaso Growth Takes Center Stage", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPS3pKeDZnTmVBOGtyY0h4WjNORDRHQkNVLUxJazFqaGtmQjM1TjZMa1pZc21xWTAxV3BxM1RaMjlHOXpvMmZjal9McHAwRU9teE43bjU4dmJxQllWaWNWajdUeklMSV8xWWszZmlrODMzY1FYX2czRW9xamVyNV92RDFQcGpqYWlib3poV21zX0pNaU1EVHNLVFQ1TQ?oc=5", "source_name": "EBC Financial Group", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQW9VaDBFcDdLbndQQnBTM2gtWGo4U1pYTC0xU1dYNXVwdzNiaUxSS1FiMHJsWGNIWnNkOVNKc3BGWXhZZ1RKdFowWXYzTkoxMEdzc1VfTlJVRlFEUjZZczJLdm1TRDBDUUR5M0hPc1YtLW4yVlRyNjlaaFpLOG5jV2ZrNzh0bzZVU04wV3NmSkZKbWs2dmFsb3YzbmpUVW04cTk5eE5ORUtlTktJVGFYNGYxdkhabGFr?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics shares surge after positive IPF trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUjFoSVY4cldmQjNVckVnUnVPc2wxa1R3REhIODJYWFo2SHp6OUdsUUs3NDVRRWw2ZlF6aVJSR0JsdWoxTF9ZQk01Um9LckxfTXRPblFzQnlXRjRxaEVTMU01SEZLTS0zNnRwUTl5V0JKQ2VMU001SVJFSFJWRnZfbE03WktDR1pyTDBTRGh1YW5leVVlbUZLMjJnVVVibTU4VHF4ZmY5RjJkdmZPWmVTUjVUM0VnQWFjeGpuejU4ZmpZeDVnRnljN2R0c2Y4LW0zSmc?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Surges Amid Successful Phase 3 Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOZmhRUTRXUV9QbjZYUnpjUG9kVmdEU3g0TW5zeV9JM2x0V3ZuLUtuYmJyaF9qNFBJY204UXhFeEdMMndsT1RUc0cyenNNbGwtWUJTdmdtUFowdDNwTnlkQWFSUkl5Nk82TE1RczY1NHZrTFI4WUp3VnB6SVBmdExpUEFoZlZkRlhQMVBJdlpHQnk?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics (UTHR) Plans New Inhaler, Impacting MannKind (MNKD) and Liquidia (LQDA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWHBXVG1BT3NhYl9KTF9femNQU1hDZU95M3BHVU1hU1c1dVVoaWNQSHhfeERFMzlYbWl2V2xCSVhKZDd6X0ZvcDdKTHhjeTQxV0hjbVZld2phXzNpQk5rdF9fLXBaZnZCel9hNWdNUWlHeGhwY0FjUUlndlVCU3ZBZWlXWnc3cGtxWkMwWDROOGlKUzE3elBac09MRUd0QkVvb1dkYlJaSk4tNUI3X2F5ejV6N3Y3X1FhMDYtUThMQXo2YlVyaVhzcTU2WkdNOXZF?oc=5", "source_name": "GuruFocus", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNSUpOanNhMFQweksyc0dtcG9RUDlvTHZuczllWHRXTkxLZFpOckphOTdjd1g0ZFU2RUZKTUhQNXIxblJ2Z0UyLW1iS0ZUeWVEZ0JPeDNxOUJtN3dvTExMNVFFRjNhWWQ4SENPV3JnZXZJTloxTTBBd3hiWVhOMTltbC1nQWg5dm9ORnRQSnFIcXJPRGV0WGhPbw?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tvardi Therapeutics\u2019 stock crashes on Phase II IPF flop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQWVpQU3dvNHQ0QW43RmVsNkg4djU2TGhtVHJPd0VuM3hfdzBOb09wQzdvOUtfRlNQSmFrVmNUUmhFWDNLYm1odHdUNDB0bENZU3FndzR1Wmt2cW5qX2tTU0U3cWRzOGZxSXpncU05Y1dDSmJRSHZ6eXlLcGJaVlNlcHhZUXgwU2RpWVY2N3NacUkyYjBuLXY1WEo5NG8?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2025-10-14T07:00:00+00:00", "published_display": "14 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwJBVV95cUxObklCSTYxN2FKVkcycnhKWjRFVUsxdjlLQzZ3bTNMcjQtaXFnd0RNRzNNNVhlN3R3UGpTbExkenRuX0FnSGI5cEtDZ3FMTnBkN0hsYmd6SEZkcE41U3p0MEM2dW9QQ1ptODNESzduMzlrUjhaWnlPNUNIbkpzYXRydFc5R2owcVFVcGJXZVUxMlBsMkFoT093MHpOQzJLd1ZOaHluT1hUd1U2akR1SUg1aUkzU01fWHJJYjY1ZVZ3ck5vWWNMc1Etemt0QWN1LXVvUU90UzYyMGJTWktzTVIzUW5rM2ZKcU91VEtkNUZRaHc5WVB0VFlDMmZIS3FtZGg2WDNRbG5WZ2pEUWF1eXE3YlFCcEt4aGdVdWNFcmNVQUFQdWtvQ2xORGVmeUhxSnY2RDJRZnY3ekFjcU5tOFctbHRHNFRWc0VKRWJQWkJYQQ?oc=5", "source_name": "GuruFocus", "published_at": "2024-03-19T07:00:00+00:00", "published_display": "19 Mar 2024 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Th", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNT3FPdFI2d1dEalpMLW84Wm5qektiS092ZUJoWk9KTjl5bzFCYmxYSmlxMFByS05IeDJlU1pWV0F3bVdORFJxQVNOcUVLNHBkZm5EZmpKd085YjVDNmhoSkhLSy1DMF9mTXc3QVlQM0xzdmI4LUxqV3dJa0lGODVZd3NaSUp1U19PaVYxa29SR2lpTzFrZGFDTk9RNE1wUnRTdl9oSHJnREkwaU9IVWNncFhzd0JMUmZ2WGNEenJLcWREZzBIdjlFcFctVVZMd0tRVFllQzY4Tml1M2VFUThOR2hnNGtXT3ZVWGhF?oc=5", "source_name": "GuruFocus", "published_at": "2023-09-22T07:00:00+00:00", "published_display": "22 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Stock Price Forecast. Should You Buy UTHR?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBfVHlNRnNWM3dOWm9wRVE4Qld3bWNpT2d0YU1ycXRRM290cUNPazI1bkNGcHMyN3F6YzB4Qm9UNTBoNXB3NVVGcg?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-02T23:54:21+00:00", "published_display": "02 Dec 2020 23:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "United Therapeutics director Jan Malcolm sells $178,941 in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPeDVKWGdMVFVJT1FSRWhfaHNJWTB0S2xVb0o5SnYtRzZqdk9fQWlfWTdNQ3VUdGlZUUwyUEJ0ZkZzUmhYRFZ2N3pQT2pDbDZFZXdncFByMEo4UEItR0prWFk2Z2NRdEJEUG1KVW1faTVjc200cnpTOGpWSE1fX2hVRkZHU3JxbktwOVQwMUYyQ1FYMk1hTFVHRmtuQ0QzS3JMQndSTVlmay1hLVNUdm1tOWhiV1IwT3dpZHVuWERtVGs?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-10T20:44:02+00:00", "published_display": "10 Jul 2026 20:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Corp (UTHR) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 88/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNM0FTSkpGUHg3LVNHY0RXeTllTEVCeEc2RFRvaDZ3aVN0b2hnS3cwRGJKOFlLMmw4RFFsNnpOSVJHY2k4RmZYUnE3bWhoTU1BX2w1LURlTS13S1N5VUgxZTFmZC1FTzBmQVZmTFZ6TkFxbnFpdEx1cnh6NFFETGNQaFJwUWVFQjRLVWo4M3QzSDFjakNfek9ZR0wzdVZnWEs1bmxrb0VJdWNwMW9QYTVPNU1pcERXWnlnYXA3Z3NsVlpUekhaME9pQ1B0dThIZjlkMFE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-07T22:33:28+00:00", "published_display": "07 Jul 2026 22:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics CEO Rothblatt sells $5.2m in company stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPVXVQVkxPSHZrVThFMGxBYTd6dEpCdEFhUm9YNUpuRi1va1JLckVFcXg0dTRFcmVPUHJEM3NONFZ1bXlSVzZTMmttclFObGFscEtBcnBmNzYwUVJCdlhOcUdDb2FEb3dtbFM2VF9GT0xfNFZOMkdpNkN3X3l5QmE5NElaN0YwT3c0enREa1lpNDVqNU1Ia2xSbnV4OUYzaS0zX0lkNEVKdDlkSWZjN2lIWmFUb1dPSjJMVWNXQ1ZwVmRQbkNVT05QZnlJZ3NKUQ?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-07T18:54:01+00:00", "published_display": "07 Jul 2026 18:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Earnings Preview: Tyvaso Growth Takes Center Stage", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPS3pKeDZnTmVBOGtyY0h4WjNORDRHQkNVLUxJazFqaGtmQjM1TjZMa1pZc21xWTAxV3BxM1RaMjlHOXpvMmZjal9McHAwRU9teE43bjU4dmJxQllWaWNWajdUeklMSV8xWWszZmlrODMzY1FYX2czRW9xamVyNV92RDFQcGpqYWlib3poV21zX0pNaU1EVHNLVFQ1TQ?oc=5", "source_name": "EBC Financial Group", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQW9VaDBFcDdLbndQQnBTM2gtWGo4U1pYTC0xU1dYNXVwdzNiaUxSS1FiMHJsWGNIWnNkOVNKc3BGWXhZZ1RKdFowWXYzTkoxMEdzc1VfTlJVRlFEUjZZczJLdm1TRDBDUUR5M0hPc1YtLW4yVlRyNjlaaFpLOG5jV2ZrNzh0bzZVU04wV3NmSkZKbWs2dmFsb3YzbmpUVW04cTk5eE5ORUtlTktJVGFYNGYxdkhabGFr?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics shares surge after positive IPF trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUjFoSVY4cldmQjNVckVnUnVPc2wxa1R3REhIODJYWFo2SHp6OUdsUUs3NDVRRWw2ZlF6aVJSR0JsdWoxTF9ZQk01Um9LckxfTXRPblFzQnlXRjRxaEVTMU01SEZLTS0zNnRwUTl5V0JKQ2VMU001SVJFSFJWRnZfbE03WktDR1pyTDBTRGh1YW5leVVlbUZLMjJnVVVibTU4VHF4ZmY5RjJkdmZPWmVTUjVUM0VnQWFjeGpuejU4ZmpZeDVnRnljN2R0c2Y4LW0zSmc?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Surges Amid Successful Phase 3 Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOZmhRUTRXUV9QbjZYUnpjUG9kVmdEU3g0TW5zeV9JM2x0V3ZuLUtuYmJyaF9qNFBJY204UXhFeEdMMndsT1RUc0cyenNNbGwtWUJTdmdtUFowdDNwTnlkQWFSUkl5Nk82TE1RczY1NHZrTFI4WUp3VnB6SVBmdExpUEFoZlZkRlhQMVBJdlpHQnk?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics (UTHR) Plans New Inhaler, Impacting MannKind (MNKD) and Liquidia (LQDA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWHBXVG1BT3NhYl9KTF9femNQU1hDZU95M3BHVU1hU1c1dVVoaWNQSHhfeERFMzlYbWl2V2xCSVhKZDd6X0ZvcDdKTHhjeTQxV0hjbVZld2phXzNpQk5rdF9fLXBaZnZCel9hNWdNUWlHeGhwY0FjUUlndlVCU3ZBZWlXWnc3cGtxWkMwWDROOGlKUzE3elBac09MRUd0QkVvb1dkYlJaSk4tNUI3X2F5ejV6N3Y3X1FhMDYtUThMQXo2YlVyaVhzcTU2WkdNOXZF?oc=5", "source_name": "GuruFocus", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNSUpOanNhMFQweksyc0dtcG9RUDlvTHZuczllWHRXTkxLZFpOckphOTdjd1g0ZFU2RUZKTUhQNXIxblJ2Z0UyLW1iS0ZUeWVEZ0JPeDNxOUJtN3dvTExMNVFFRjNhWWQ4SENPV3JnZXZJTloxTTBBd3hiWVhOMTltbC1nQWg5dm9ORnRQSnFIcXJPRGV0WGhPbw?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tvardi Therapeutics\u2019 stock crashes on Phase II IPF flop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQWVpQU3dvNHQ0QW43RmVsNkg4djU2TGhtVHJPd0VuM3hfdzBOb09wQzdvOUtfRlNQSmFrVmNUUmhFWDNLYm1odHdUNDB0bENZU3FndzR1Wmt2cW5qX2tTU0U3cWRzOGZxSXpncU05Y1dDSmJRSHZ6eXlLcGJaVlNlcHhZUXgwU2RpWVY2N3NacUkyYjBuLXY1WEo5NG8?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2025-10-14T07:00:00+00:00", "published_display": "14 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwJBVV95cUxObklCSTYxN2FKVkcycnhKWjRFVUsxdjlLQzZ3bTNMcjQtaXFnd0RNRzNNNVhlN3R3UGpTbExkenRuX0FnSGI5cEtDZ3FMTnBkN0hsYmd6SEZkcE41U3p0MEM2dW9QQ1ptODNESzduMzlrUjhaWnlPNUNIbkpzYXRydFc5R2owcVFVcGJXZVUxMlBsMkFoT093MHpOQzJLd1ZOaHluT1hUd1U2akR1SUg1aUkzU01fWHJJYjY1ZVZ3ck5vWWNMc1Etemt0QWN1LXVvUU90UzYyMGJTWktzTVIzUW5rM2ZKcU91VEtkNUZRaHc5WVB0VFlDMmZIS3FtZGg2WDNRbG5WZ2pEUWF1eXE3YlFCcEt4aGdVdWNFcmNVQUFQdWtvQ2xORGVmeUhxSnY2RDJRZnY3ekFjcU5tOFctbHRHNFRWc0VKRWJQWkJYQQ?oc=5", "source_name": "GuruFocus", "published_at": "2024-03-19T07:00:00+00:00", "published_display": "19 Mar 2024 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Th", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNT3FPdFI2d1dEalpMLW84Wm5qektiS092ZUJoWk9KTjl5bzFCYmxYSmlxMFByS05IeDJlU1pWV0F3bVdORFJxQVNOcUVLNHBkZm5EZmpKd085YjVDNmhoSkhLSy1DMF9mTXc3QVlQM0xzdmI4LUxqV3dJa0lGODVZd3NaSUp1U19PaVYxa29SR2lpTzFrZGFDTk9RNE1wUnRTdl9oSHJnREkwaU9IVWNncFhzd0JMUmZ2WGNEenJLcWREZzBIdjlFcFctVVZMd0tRVFllQzY4Tml1M2VFUThOR2hnNGtXT3ZVWGhF?oc=5", "source_name": "GuruFocus", "published_at": "2023-09-22T07:00:00+00:00", "published_display": "22 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Therapeutics Stock Price Forecast. Should You Buy UTHR?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBfVHlNRnNWM3dOWm9wRVE4Qld3bWNpT2d0YU1ycXRRM290cUNPazI1bkNGcHMyN3F6YzB4Qm9UNTBoNXB3NVVGcg?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-02T23:54:21+00:00", "published_display": "02 Dec 2020 23:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 51, "total_relevant": 13, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 8, "score": 55, "total": 13, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 137.5, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 0.0, "twelve_week_move": -10.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.96084, "market_dynamics_buy_signal": false, "relative_strength": 1.87402, "fair_value_gap": 44.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 26.268, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +0.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GuruFocus", "count": 4}, {"label": "Investing.com South Africa", "count": 2}, {"label": "Market source", "count": 2}, {"label": "EBC Financial Group", "count": 1}, {"label": "Proactive financial news", "count": 1}, {"label": "timothysykes.com", "count": 1}, {"label": "Clinical Trials Arena", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 2}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +0.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "United Therapeutics director Jan Malcolm sells $178,941 in stock By Investing.com"}], "updated_at": "2026-07-17T22:32:43.857123+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}